Trials / Unknown
UnknownNCT06086405
ECMO Braile Biomédica® in COVID-19 Patients
ECMO Braile Biomédica® in COVID-19 Patients Post-market Clinical Trial to Verify the Performance of the ECMO System
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Braile Biomedica Ind. Com. e Repr. Ltda. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Retrospective data collection to evaluate the gas transfer capacity of the Braile Biomédica® OxyPrime® ECMO BRCoating® Membrane Oxygenator in COVID-19 patients during the pandemic.
Detailed description
Multicenter, retrospective, non-comparative, non-randomized study to assess the clinical performance of the OxyPrime® ECMO BRCoating® Membrane Oxygenator in adult patients with COVID-19
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Patients underwent cardiorespiratory support | Patients underwent cardiorespiratory support using the Oxyprime® ECMO Braile Biomédica® Membrane Oxygenator |
Timeline
- Start date
- 2023-09-14
- Primary completion
- 2024-01-01
- Completion
- 2024-03-01
- First posted
- 2023-10-17
- Last updated
- 2023-10-17
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT06086405. Inclusion in this directory is not an endorsement.